Table 1.

Demographic and clinical characteristics of HIV-1-seropositive and -seronegative subjects

Group and subjectaAge (yr)SexbRaceNo. of CD4+ T cells/mm3No. of HIV-1 RNA copies (log10 copies/ml)
HIV-1-seropositive subjects
    10242FNative American6823.89
    10534MNative American5684.66
HIV-1-seronegative subjects
  • a Asterisks denote the subjects who previously received antiretroviral therapy. At the time of enrollment in this study, they had been off therapy for 6 months or longer.

  • b M, male; F, female.